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CytokinesIt remains unclear whether monocyte inﬁltration plays a protective or detrimental role in neurodegenerative
disease. The present study characterizes the inﬂammatory status of primary monocytes in a novel in vitro
perfusion model. Monocytes under perfusion do not undergo elevated cell death. However, perfusion does
lead to altered morphology, which can be counteracted by anti-inﬂammatory drugs. Functional studies indi-
cate that cytokine levels are signiﬁcantly reduced in perfusion compared to stationary conditions and en-
hanced with brain slices or capillary endothelial cells. Understanding monocyte properties could lead to
reﬁned treatment and new ways to interfere with inﬂammation in diseased brains.
© 2013 Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Monocytes are bone marrow-derived hematopoietic cells that cir-
culate throughout the bloodstream and eventually give rise to tissue
macrophages and dendritic cells (Ziegler-Heitbrock, 2007). Peripher-
al monocytes consist of a wide variety of phenotypically and function-
ally distinct subpopulations varying in maturation, differentiation,
and activation states. These heterogeneous subpopulations are char-
acterized by their differential expression of cell surface markers
(Auffray et al., 2009; Buckner et al., 2011). Inﬂammation and the re-
cruitment of monocytes and monocyte-derived cells into the central
nervous system (CNS) have been implicated in a number of neurolog-
ical disorders including: Alzheimer's disease (AD), Parkinson's dis-
ease (PD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis
(MS) (Akiyama et al., 2000; Glass et al., 2010; Khandelwal et al.,
2011). Upon pathological stimulation (including neurodegeneration
or inﬂammation) or during normal immune patrol, monocytes ad-
here and transmigrate across the blood–brain barrier (BBB) into the
brain where they execute effector functions and differentiate into
cells with a microglia-like phenotype. This migration is mainly regu-
lated by cell adhesion molecules (CAMs) and chemokines (Auffray
et al., 2007; D'Mello et al., 2009; Prinz and Priller, 2010).
Extensive evidence indicates that inﬂammation can contribute to
further exacerbation of neurodegenerative diseases. In the healthy
brain and CNS tissue, inﬂammatory mediators (cytokines and their re-
ceptors) are expressed constitutively at low or undetectable levels.hotherapy, Anichstr, 35, A-6020
12 504 23713.
mpel).
-NC-ND license.However, upon insult or infection, proinﬂammatory cytokines and me-
diators lead to the expression of chemokines and adhesion molecules,
recruitment of monocytes and other immune cells to the lesion site,
and activation of resident microglia and/or astrocytes. Thus far, the
role of monocytes and monocyte-derived cells in disease propagation
has been under intense debate. Monocyte-derived macrophages may
induce beneﬁcial effects by their secretion of neuroprotective factors,
phagocytosis of debris/apoptotic cells and initiation of repair processes
(Schwartz and Shechter, 2010). Previous investigations indicate that
microglia cause further disease aggravation through uncontrolled in-
ﬂammation via release proinﬂammatory mediators and other neuro-
toxic factors (Lucas et al., 2006). Therefore, further studies are needed
in order to better understand the phenotype and migratory dynamics
of monocytes during inﬂammation of the CNS.
However, studies involving primary monocytes have proven difﬁ-
cult. In vitro static culturing methods using glass or plastic vessels
quickly lead to monocyte adherence, activation, and differentiation
into macrophages (Steiniger et al., 2001). Few studies have shown the
successful maintenance of monocyte cultures in the absence of growth
factors (M-CSF, GM-CSF) or differentiation (Wirth et al., 1982; Maoz et
al., 1986). Thus, we sought to establish an in vitro culturing system that
provides more physiological conditions.
The aim of the present study is to characterize the inﬂammatory
status of primary rat monocytes in a novel in vitro perfusion model.
This model consists of two peristaltic pumps providing constant
ﬂow of medium and cell circulation into a glass chamber applying
shear stress (Fig. 1).
Here, we compare the functional properties of monocytes after
isolation, exposure to constant ﬂow, and incubation under static con-
ditions. In addition, we evaluate the interaction between monocytes
Fig. 1. Schematic diagram of a novel in vitro perfusion system. The system consists of a peristaltic pump (A) which pumps pre-warmed (37 °C) mediumwith a ﬂow rate of 5 ml/min
into a glass Petri dish. A second peristaltic pump (B) pumps the medium back into the medium container allowing recirculation. The glass chamber (glass Petri dish) is located in an
incubator at 37 °C and 5% CO2. The system is connected via plastic tubes (arrows). An inlet in the medium container allows the addition of different substances and cells under
sterile conditions. In the glass chamber small membrane inserts containing brain slices or brain capillary endothelial cells can be incubated under constant ﬂow of culture medium.
The system also contains an outlet for cell and media collection following the experiment.
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under the inﬂuence of constant ﬂow including their release of inﬂam-
matory markers. Finally, we examine the effects of anti-inﬂammatory
drugs (i.e. minocycline, indomethacin) on counteracting release of
proinﬂammatory cytokines in cortical organotypic brain slices.
2. Methods
2.1. Isolation of primary rat monocytes
Primary rat monocytes were freshly isolated as previously described
by us with some modiﬁcations (Humpel, 2008; Böttger et al., 2010;
Hohsﬁeld and Humpel, 2010). In brief, Sprague–Dawley rats (250 g,
Himberg, Austria) were anesthetized by an intraperitoneal injection of
40 mg/kg bodyweight thiopental (Sandoz, Kundl, Austria) and perfused
with 500 ml of 4 °C pre-chilled 10 mM phosphate-buffer saline (PBS)/
2.7 mM EDTA/25 mg/ml heparin, pH 7.3 through the left ventricle.
The collected efﬂuent was centrifuged at 550 ×g for 10 min at 4 °C.
The perfusate pellet was resuspended in 50 ml of 10 mMPBS/1% bovine
serum albumin (BSA; SERVA Electroporesis, Heidelberg, Germany)/
2.7 mM EDTA, pH 7.3 and carefully overlaid on a Percoll working solu-
tion (Scriba et al., 1996). After centrifugation at 500 ×g for 30 min at4 °C, peripheral blood mononuclear cells (PBMC) were harvested from
the interphase. PBMC were then washed once with 50 ml of PBS and
~20 × 106 PBMC were resuspended in 100 μl of PBS/BSA/EDTA. Mono-
cytes were puriﬁed from PBMC by negative magnetic selection: PBMC
were incubated in a cocktail consisting of four different puriﬁed anti-
rat monoclonal antibodies (20 μg of each: CD8a (clone OX-8), CD5
(clone OX-19), CD45RA (clone OX-33), PAN T (clone OX-52); all from
Cedarlane Laboratories, Szabo, Austria) for 10 min at 4 °C shaking.
PBMC were washed once with PBS and resuspended in 100 μl of PBS/
BSA/EDTA and 40 μl of MACS Goat Anti-Mouse-IgG Microbeads
(Miltenyi Biotec, Bergisch Gladbach, Germany). PBMC were incubated
for 15 min at 4 °C on a shaker and following incubation, were washed
once with PBS. The cells were resuspended in 1000 μl of PBS/BSA/
EDTA and then applied to a MS-MACS column ﬁxed to a strong magnet.
The puriﬁed monocytes were centrifuged and pooled for further exper-
iments. Approximately 10 × 106 cells were isolated from one adult rat.
The described isolation procedure yields approximately 90–95% CD68-
positive monocytes (Moser and Humpel, 2007; Böttger et al., 2010).
During this preparation monocytes were counted using the Cell Coulter
Counter (COULTER®Z™ Series, Fischerlehner & Kucera, Innsbruck,
Austria) in a range from 5.5 to 10 μm. All animal experiments were ap-
proved by the Austrian Ministry of Science and conformed to the
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stepswere taken toward reducing the number of animals used and their
suffering.
2.2. In vitro perfusion system
The perfusion system consists of two peristaltic pumps (P-1 Pump,
Pharmacia, London, UK) providing a constant ﬂow rate of 5 ml/min
(~3 dyn/cm2 shear stress level) similar to the levels at post-capillary ve-
nules where leukocytes exit the blood (Resto et al., 2008). Prior to perfu-
sion, the autoclaved glass container and the autoclaved glass Petri dish are
connected to a 320 cm long tube system (silicone tubes, 3 mm inner di-
ameter, 5 mm outer diameter, UniLab Politakis, Innsbruck Austria) and
washed with 100 ml of 70% ethanol for 30 min, followed by 2 washes
with sterile a.d. (100 ml each for 30 min). Then 37 °C pre-warmed sterile
ﬁltered culture medium is added to the system via a ﬁlter (0.4 μm)
connected to a syringe and circulated for 30 min at 37 °C and 5% CO2.
One pump delivers the sterile culture medium to the glass chamber and
the second pump carries the medium out of the chamber and back into
the medium container allowing recirculation (Fig. 1). The medium is
composed of 50% MEM/HEPES (GIBCO Invitrogen), 25% heat inactivated
horse serum (GIBCO Invitrogen), 25% HBSS (GIBCO Invitrogen), 2 mM
NaHCO3 (Merck), 6.5 mg/ml glucose (Merck), and 2 mM glutamine
(Merck) at pH 7.2. For some experiments brain slices or BCEC (grown
on either 3 μmpore sizemembrane inserts allowingmonocytemigration
or 0.4 μm pore size inserts that do not permit transmigration) are
inserted into the Petri dish glass chamber. Following this preparation,
5 × 106monocytes (Lebson et al., 2010) or different substances (e.g. lipo-
polysaccharide (LPS), minocycline, etc.) are added sterilely to the perfu-
sion system via an inlet in the medium container. Once the cells or
substances have been added, they are also then pumped along with the
medium resulting in continuous circulation. Following 24 hof incubation,
the culture medium, monocytes, BCEC and brain slices are collected for
further analysis. The perfusion system is then washed with ethanol and
distilled water and disconnected and prepared for another experiment.
In order to visualize effective monocyte transmigration, monocytes
were labeled with PKH67 Green Fluorescent Cell Linker (Sigma-
Aldrich) according to manufacturer's instructions as previously de-
scribed (Böttger et al., 2010) prior to their addition into the perfusion
system. LPS (1 μg/ml) was used to stimulate an inﬂammatory response
in the perfusion model. As negative controls — monocytes and brain
slices/BCEC were cultured alone or together without LPS. Minocycline
(30 μM), ibuprofen (50 μM), and indomethacin (1 μM) were added to
the system to observe the effects of anti-inﬂammatory drugs on coun-
teracting inﬂammation.
2.3. Preparation of cortical organotypic brain slices
The use of organotypic brain slices has been well established and
previously described by us in detail (Moser et al., 2003; Pirchl et al.,
2010). Brieﬂy, cerebral cortices from postnatal day 8 (P8) rats were
dissected under aseptic conditions and cut to a thickness of 400 μm
using a McIlwain Tissue Chopper (Mickle Laboratory, Surrey, UK).
Cortex slices were then placed on Millicell 0.4 μm pore size 30 mm
diameter cell culture inserts or Millicell-PCF 3 μm pore size 12 mm
diameter (for transmigration studies) cell culture inserts (2 slices
per membrane, Millipore). Slices were cultured for approximately
2 weeks at 37 °C/5% CO2 with 1.2 ml/well of the following culture me-
dium: 50% minimum essential medium (MEM)/4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES) (GIBCO Invitrogen, Paisley,
UK), 25% heat-inactivated horse serum (GIBCO Invitrogen), 25% Hanks'
Balanced Salt Solution (HBSS; GIBCO Invitrogen), 2 mM NaHCO3
(Merck, Darmstadt, Germany), 6.5 mg/ml glucose (Merck), and 2 mM
glutamine (Merck), pH 7.2. The medium was changed twice a week.
After 2 weeks of incubation, the slices became attached to the mem-
brane of the culture inserts and the inserts were placed into the glasschamber of the perfusion system (already containing medium) for
24 h. Following experiments, slices were washed with PBS and either
collected as extracts for ELISA analysis or immediately investigated
under the microscope.
2.4. Rat brain capillary endothelial cell culture
The culturing of rat brain capillary endothelial cell (BCEC)-monolayers
was performed as describedpreviously (Moser et al., 2004). Immortalized
brain capillary endothelial cells (rBCEC4; Blasig et al., 2001)were cultured
on collagen-coated wells (5 μg/cm2 rat tail collagen, Roche Diagnostics,
Mannheim, Germany) in full BCEC medium (13.5 mg/ml Dulbecco's
modiﬁed Eagle's medium (DMEM), Sigma-Aldrich, Steinheim, Germany;
10% heat-inactivated fetal bovine serum (FBS), PAA Laboratories,
Pasching, Austria; 100 μg/ml heparin, Sigma) at 37 °C/5% CO2. After
2–3 days, the cells were then scraped and placed onto the outer mem-
brane of inverted collagen-coatedMillicell 0.4 μmpore size 30 mmdiam-
eter cell culture inserts or Millicell-PCF 3 μm pore size 12 mm diameter
(for transmigration studies) cell culture inserts (Millipore, Carrigtwohill,
Ireland). Following 3 h incubation, BCEC adhered to the membrane in-
serts andwere thus turned right side up andmaintained in full BCECme-
dium for 1 day. This plating technique ensured that BCEC came in direct
contact with perfused medium and cells (similar to their formation of a
capillary wall) thereby providing an in vitro blood–brain barrier. Follow-
ing incubation, the culture mediumwas changed and cells were incubat-
ed in full BCEC medium containing hydrocortisone (500 ng/ml, Sigma)
for 1 day. Following incubation, cells were placed in BCECmediumwith-
out FBS andmaintained for 1–2 weeks. After 1–2 weeks BCECdisplayed a
fully conﬂuent monolayer and were used for experimental purposes. To
verify cell conﬂuency, some cells (plated in parallel) were stained for nu-
clear DAPI distribution (30 min, 1:10,000, Sigma) one day prior to the ex-
periment. Only cells displaying a fully conﬂuentmonolayerwere used for
perfusion studies. Following perfusion experiments, BCEC were washed
with PBS and either collected as extracts for ELISA andWestern blot anal-
ysis or stained for immunohistochemical evaluation. To evaluate cell
integrity following perfusion, some BCEC were ﬁxed and stained for
tight junction (ZO-1, 1:100), F-actin (phalloidin-TRITC, 45 min, 1:2000,
Fluka/Sigma-Aldrich), and DAPI (20 min, 1:10,000, Sigma) distribution.
2.5. Immunohistochemistry
Immunohistochemistry was performed as previously described
(Moser et al., 2006; Humpel, 2008). For evaluation of surfacemarker ex-
pression, monocytes were spotted on collagen-coated glass slides and
ﬁxed in cold 4%paraformaldehyde/10 mMPBS (4 °C, 30 min). Afterﬁx-
ation, cells were washed with PBS and then incubated in PBS/0.1%
Triton (T-PBS) for 30 min at 20 °C shaking. After incubation, the cells
were then blocked in T-PBS/20% horse serum (GIBCO Invitrogen)/0.2%
BSA (SERVA) for 30 min at 20 °C shaking. Following blocking, mono-
cytes were incubated with primary antibody: ED-1 (CD68, 1:750,
Chemicon Millipore, Temecula, CA, USA), OX-42 (CD11b, 1:500,
Chemicon Millipore), ionized calcium binding adaptor molecule-1
(Iba-1; 1:500, Wako Pure Chemical, Osaka, Japan) in T-PBS/0.2% BSA
overnight at 20 °C. The cells were thenwashed and incubatedwith sec-
ondary antibody Alexa Fluor 488 anti-mouse (ED-1, OX-42) or anti-
rabbit (Iba-1) (1:200, Molecular Probes Invitrogen, Eugene, CA, USA)
in T-PBS/0.2% BSA for 1 h at 20 °C shaking. Cells were then mounted
with a glass coverslip using Vectashield Mounting Medium (Vector
Laboratories, Burlingame, CA, USA) and visualized under the micro-
scope. Alternatively, immunoperoxidase staining was performed using
Vectastain Elite ABC kit (Vector Laboratories). Monocytes were ﬁxed
and washed in T-PBS as usual. To quench endogenous peroxidase,
cells were treated with PBS/1%H2O2/5% methanol. Cells were then
washed, blocked, and incubated with primary antibody as usual. After
washes, cells were incubated with biotinylated secondary antibody
(1:200, Vector Laboratories). After rinsing with PBS, cells were
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oratories) for 1 h at 20 °C shaking. Finally, the cells were washed with
50 mM Tris-buffered saline (TBS) and then incubated in 0.5 mg/ml
3,3′-diaminobenzidine (DAB, Sigma)/TBS/0.003% H2O2 at 20 °C in the
dark until signal was detected. Once DAB staining was visible, the reac-
tion was stopped by adding TBS to cells. Cells were rinsed with TBS and
then evaluated by microscopy. Images were captured with a Leica DM
IRB (Leica DFC350FX camera) or Olympus BX61 (ProgRes C14 camera)
microscope equippedwith Openlab 4.0.4 or Openlab 5.5.0 imaging soft-
ware, respectively.
2.6. Flow cytometry
Monocyte cell death was evaluated by in situ staining of non-ﬁxed
cells with the nuclear dye propidium iodide (PI). Cell death was de-
termined by analyzing the number of PI-positive cells using ﬂow cy-
tometry (BD FACS Calibur). In brief, cells were washed with PBS and
incubated in 2 μg/ml PI (Moser et al., 2006) immediately prior to
evaluation.
2.7. Searchlight Multiplex ELISA
The detection of inﬂammatory proteins (monocyte chemotactic
protein-1, MCP-1; macrophage inﬂammatory protein-2, MIP-2; tumor
necrosis factor-α, TNFα; interleukin-1β, IL-1β) was performed using the
Thermo Scientiﬁc SearchLight Protein Array Technology (THP Medical
Products, Vienna) according to the manufacture's recommendations
(Bio-Rad) and as previously described by us (Hohsﬁeld and Humpel,
2010; Hochstrasser et al., 2011). Brieﬂy, collected culture medium, cell
extracts (diluted 1:2 in diluent) or calibrated standards were added to
coated wells of the provided plate and incubated for 3 h. After
washing, the biotinylated antibodies were added and following
30 min incubation the wells were washed again and incubated with
streptavidin-horseradish peroxidase conjugate. After the ﬁnal washing
step the SuperSignal Chemiluminescent Substrate was added. All incu-
bation stepswere carried out on a shaker at 20 °C. The luminescent sig-
nal was detected using a compatible CCD imaging and analysis system
and the absorbance was measured at 450 nm. The concentration of
each sample was quantiﬁed by comparing the spot intensities with
the corresponding standard curves calculated from the standard sample
results using the SearchLight Array Analyst Software. Integrated density
valueswere proportional to the concentrations of bound proteins. Stan-
dard curves, raw data and ﬁnal pg/ml concentrations for each analyte
and each sample were reviewed in the array software and exported to
Microsoft Excel Software for further statistical analysis. Sample values
were calculated from the standard curve in a linear range.
2.8. Quantitative analysis and statistics
All data are depicted as mean ± SEM (n = independent experi-
ments). Statistical analysis was obtained by one-way ANOVA or Inde-
pendent T-test with Fisher LSD post hoc test, comparing controls
against respective treatments in which p b 0.05 represents the mini-
mum level of statistical signiﬁcance.
3. Results
3.1. Cell phenotype and viability of primary rat monocytes
Primary rat monocytes were stained for monocyte/macrophage
markers: ED-1 (CD68), OX-42 (CD11b), and Iba-1 (Fig. 2). ED-1 staining
was mostly restricted to the cytoplasm with occasional intense intracel-
lular vesicle staining (Fig. 2B). OX-42 labeling was mostly localized on
the cell surface (Fig. 2C). Iba-1 staining was distributed throughout the
entire cell (Fig. 2D). Previous studies by us have shown that these cells
display strong immunostaining (90%) for CD172a (ED-9) (Zassler andHumpel, 2006). Monocytes cultured under static conditions (i.e. in an
eppendorf tube or 24-well plate) and ﬂow conditions displayed similar
immunostaining of monocyte/macrophage speciﬁc markers to freshly
isolated cells by microscopy evaluation (Fig. 2). Conﬁrming the data by
ﬂow cytometry analysis, we observed that the majority (70–95%) of
freshly monocytes expressed typical surface markers ED-1 and OX-42
(data not shown). Directly following isolation, monocytes were also
stained with the membrane linker dye PKH67. This labeling did not re-
sult in an altered cell size or morphology. Naïve primary rat monocytes
displayed a diameter of approx. 6 μm following isolation and staining
(Figs. 2F and 3A). This cell size and morphology appeared unaltered in
monocytes incubated under static conditions (Fig. 2). The majority of
freshly isolated cells and cells incubated for 24 h under static conditions
exhibited small and round morphologies, whereas perfused cells dis-
played multiple forms (Fig. 3B). These varying sizes and morphologies
consisted of three major groups: small and round (Fig. 3C), small and
elongated, and large and round/elongated (Fig. 3D). We observed that
the number of large and elongated cell formswas signiﬁcantly enhanced
(p b 0.001) when cells were subjected to constant ﬂow (Table 1).
Flow cytometry analysis was also carried out in order to evaluate
monocyte survival. Immediately following isolation or cultivation,
monocytes were incubated with propidium iodide (PI) and analyzed.
Approximately 13 ± 2% of freshly isolated cells were PI-positive
(n = 7). Cell death was not signiﬁcantly enhanced in monocytes incu-
bated for 24 h under static conditions compared to freshly isolated cells.
Approximately 19 ± 2% of cells displayed PI-positive staining (n = 6).
In addition, under static conditions we observed a population of cells
displaying a more granular phenotype. No signiﬁcant difference was
found in cell death between cells subjected to 24 h constant ﬂow and
cells incubated under static conditions. Speciﬁcally, 29 ± 5% of cells
subjected to constant ﬂow were PI-positive (n = 5). Under these con-
ditions we did not observe a deﬁned population of cells exhibiting
higher granularity as was seen in cells under static incubation (data
not shown). The effects of PKH67 labeling on monocyte cell death
were also evaluated by ﬂow cytometry. Approximately 9 ± 3 (n = 4)
% of cells were PI-positive and 99 ± 1 (n = 4) % were positive in the
FL-1 channel detecting green dyes.
3.2. Cytokine and chemokine secretion of primary rat monocytes
Wewere also interested in the effects of different culturingmethods
onmonocyte functional inﬂammatory behavior, speciﬁcally on their cy-
tokine and chemokine secretion.We observed that monocytes incubat-
ed under static conditions released high amounts of inﬂammatory
markers. Overall, cells incubated for 24 h in the presence of LPS under
static conditions displayed decreased release of MCP-1, MIP-2, and
TNF-α. Statistical analysis showed thatMCP-1 secretionwas slightly re-
duced (p = 0.08) and MIP-2 secretion was signiﬁcantly reduced
(p b 0.01) by LPS treatment under static conditions compared to con-
trol static conditions (Fig. 4). On the other hand, IL-1β release was
slightly, but not signiﬁcantly enhanced. Cells under constant ﬂow illus-
tratedmarkedly decreased inﬂammatorymediator release compared to
cells under static incubation. The release of these inﬂammatorymarkers
was slightly, however not signiﬁcantly increased with the addition of
LPS (Fig. 4).
3.3. Interaction of monocytes with BCEC under constant ﬂow
To evaluate the interaction of monocytes with BCEC, we incubated
monocytes in the presence of rat brain capillary epithelial cells
(BCEC) for 24 h under constant ﬂow. BCEC alone under constant
ﬂow showed high release of MCP-1 measured in the culture medium.
This high secretion was signiﬁcantly elevated by LPS treatment and
the addition of circulating monocytes (p b 0.001) under static condi-
tions, however not under constant ﬂow (Fig. 4). All other cytokines
(MIP-2, TNF-α, IL-1β) exhibited low level release or were below
Fig. 2. Immunohistochemical analysis of monocyte surface marker expression. Primary monocytes were isolated, spotted onto glass slides and immunohistochemically stained for
various surface markers: ED1 (B, E), cluster of differentiation 11b (CD11b) (C), ionized calcium binding adaptor molecule-1 (Iba-1) (D). As a control, cells were incubated without
primary antibody (A). Monocytes were also ﬂuorescently stained using PKH67 (F). Nuclei were counterstained with nuclear DAPI (A–D). Scale bar = 15 μm (A–D), 60 μm (E) and
20 μm (F).
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hanced in the presence of monocytes (p b 0.05).
We also evaluated the number of monocytes in contact with the
BCEC-monolayer. On average, 11 ± 3 (n = 8) monocytes adhered
to a BCEC-monolayer as visualized in a 113 mm2 ﬁeld (Fig. 5E–5G).3.4. Interaction of primary rat monocytes with cortex slices under con-
stant ﬂow
After observing monocyte cytokine and chemokine secretion alone
and in the presence of LPS, wewere also interested in the effects of cor-
tical organotypic brain slice and primary monocytic cell co-cultures on
inﬂammatorymarker output. Slices alone showed little to no inﬂamma-
tory marker release, with the exception of MCP-1 (Fig. 4). Slice release
in the presence of LPS was signiﬁcantly elevated compared to slices
alone (p b 0.05). Slices incubated in the presence of monocytes underconstant ﬂow and static conditions resulted in markedly enhanced se-
cretion of inﬂammatory markers into the culture medium.
In addition to measuring cytokine and chemokine secretion, we
were also interested in evaluating whether monocytes could come
in contact with the cortical brain slices and whether this interaction
resembled transmigration into or adhesion to slices. In order to visu-
alize monocyte transmigration and/or adhesion, monocytes were la-
beled with membrane dye PKH67 prior to addition to the perfusion
system (Fig. 5A). On average, 163 ± 60 (n = 11) monocytes migrat-
ed into a cortical brain slice as visualized in a 113 mm2 ﬁeld (Fig. 5B).
Furthermore, 71 ± 1% of total migrated monocytes displayed small
and round morphology (Fig. 5C) whereas the other 29 ± 1% dis-
played small and elongated morphology (n = 4, Fig. 5D).
In addition, we evaluated inﬂammatory marker release of brain
slices in the presence of circulating monocytes following treatment
with anti-inﬂammatory drugs. All three anti-inﬂammatory drugs
(minocycline, ibuprofen, and indomethacin) slightly reduced cytokine
Fig. 3. Fluorescent microscopy analysis of monocyte morphology. Primary rat monocytes were freshly isolated, labeled with ﬂuorescent dye PKH67 and evaluated immediately
(A) or following 24 h incubation in the perfusion system (B). Images illustrate different representative morphologies of cells. Observed size and morphological proﬁles include
small round cells (A, C), small elongated cells (B, D) and large (elongated or round, arrowheads) cells (B, D). Scale bar in A = 50 μm (A, B) and 10 μm (C, D).
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compared to slices incubated with monocytes alone (Table 1). Howev-
er, this reduction in MCP-1, MIP-2, and TNF-α secretion was not signif-
icant. IL-1β levels were below assay detection limits.
3.5. Effects of anti-inﬂammatory drugs on monocytes under constant
ﬂow
In order to evaluate the effects of anti-inﬂammatory drugs on the pro-
ﬁle and behavior of monocytes under constant ﬂow, we added the
anti-inﬂammatory drugs minocycline, ibuprofen, and indomethacin toTable 1
The effects of anti-inﬂammatory drugs on monocyte size/morphology and inﬂammation un
(−) Minocyclin
MCP-1 199 ± 56 (10) – 147 ± 10
MIP-2 18 ± 5 (10) – 12 ± 10 (
TNF-α 20 ± 5 (10) – BDL (4) n
% small, round cells 43 ± 2 (4) – 59 ± 4 (4
% large cells 13 ± 1 (4) – 10 ± 1 (4
% small, elongated cells 45 ± 2 (4) – 32 ± 5 (4
Inﬂammation was evaluated by the measurement of inﬂammatory markers using Searchligh
protein-2, MIP-2; tumor necrosis factor-α, TNF-α). 5 × 106 monocytes were added to the pe
indomethacin (1 μM) were added to the system to observe the effects of anti-inﬂammatory
and slices cultured in the absence of drugs. IL-1β levels were also measured, however, all s
tistical analysis was performed using one-way ANOVA with Fisher's LSD posthoc test (**p b
for varying cell sizes and morphologies. For these experiments, monocytes were labeled wit
mean ± SEM % of cells. Data not shown: Slices alone in perfusion secrete 48 ± 19 (8) pg/m
Freshly isolated monocytes display 98 ± 0.5 (4) % small, round morphology, 1.8 ± 0.5 (4)our perfusion system (containing monocytes and cortical brain slices).
We observed that minocycline in perfusion slightly enhanced (p =
0.09) the amount of small round cell forms compared to perfusion
alone (Table 1). Indomethacin treatment signiﬁcantly reduced (p b .01)
the number of large cells observed compared to non-treated samples.
4. Discussion
In the present study, we evaluated the inﬂammatory status of pri-
mary rat monocytes under constant ﬂow in an in vitro perfusion sys-
tem. In addition, we examined the effects of anti-inﬂammatory drugsder perfusion conditions.
e Ibuprofen Indomethacin
5 (4) ns 165 ± 66 (4) ns 145 ± 26 (6) ns
4) ns 6 ± 4 (4) ns 6 ± 2 (6) ns
s p = .09 12 ± 7 (4) ns BDL (6) p = .09
) ns p = .09 37 ± 13 (3) ns 40 ± 6 (4) ns
) ns 12 ± 2 (3) ns 6 ± 1 (4) **
) ns 50 ± 15 (3) ns 55 ± 5 (4) ns
t Multiplex ELISA (monocyte chemotactic protein-1, MCP-1; macrophage inﬂammatory
rfusion system containing cortical slices. Minocycline (30 μM), ibuprofen (50 μM), and
drugs in counteracting inﬂammation. (−) indicates control conditions i.e. monocytes
amples were below assay detection limits. Values = mean ± SEM, pg/ml × 24 h. Sta-
0.01; ns not signiﬁcant). Monocyte proﬁles were evaluated by ﬂuorescent microscopy
h PKH67 membrane dye immediately prior to addition to perfusion system. Values =
l MCP-1, 0.9 ± 0.2 (8) pg/ml MIP-2, however, TNF-α was below assay detection limits.
% large morphology, and no small, elongated morphology.
Fig. 4. Inﬂammatory proﬁle of primary rat monocytes. The inﬂammatory proﬁle of primary rat monocytes was evaluated by measurement of inﬂammatory markers by Searchlight
Multiplex ELISA (monocyte chemotactic protein-1, MCP-1; macrophage inﬂammatory protein-2, MIP-2; tumor necrosis factor-α, TNF-α; interleukin-1β, IL-1β). Primary rat mono-
cytes (105 cells/ml) were cultured under static or ﬂow conditions in the presence or absence of LPS, a brain capillary endothelial cell (BCEC)-monolayer or cortical brain slices. Li-
popolysaccharide (LPS) was added to the cultured cells to stimulate an inﬂammatory response. As controls, BCEC and slices were also cultivated under static or ﬂow conditions in
the presence or absence of LPS. Values = mean ± SEM, pg/ml × 24 h × 105 cells. pM static (n = 22), pM + LPS static (n = 23), pM + LPS perfusion (n = 8), pM + slice (n =
10), pM + BCEC (n = 9), slice perfusion (n = 7), and for all others (n = 6). Statistical analysis was performed using one-way ANOVA or Independent T-test with Fisher's LSD
posthoc test (*p b 0.05; **p b 0.01, ***p b 0.001). Detection limits: MCP-1: 3.13 pg/ml, MIP-2: 0.78 pg/ml, TNF-α: 6.3 pg/ml, IL-1β: 12.5 pg/ml.
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mately, we show the effects of perfusion on the monocyte inﬂamma-
tory proﬁle and demonstrate the usefulness of such a model in
evaluating monocyte-induced inﬂammation.4.1. Surface marker expression in monocytes
Rat monocytes are characterized morphologically as mononuclear
cells with bean-shaped nuclei and phenotypically by their expression
of surface markers: ED-1, ED-9 and OX-42 (CD11b; Grau et al., 2000).
ED-1 is a monoclonal antibody directed against a lysosomal mem-
brane (CD68-like) antigen. The monoclonal antibody ED-9 recognizes
a member of the signal-regulatory protein-α (SIRP-α) family. Here,
we report that isolated monocytes demonstrate strong immunoreac-
tivity with ED-1 and OX-42, as well as Iba-1, a monocyte/macrophage
lineage marker that can be an indicator for microglia activation (Imai
and Kohsaka, 2002). Several factors have been shown to change the
properties ofmonocytes (Strauss-Ayali et al., 2007), thus, it is importantto consider that different culturingmethods could also have varying ef-
fects on the phenotypic and functional properties (Buckner et al., 2011).
4.2. Culturing monocytes
Previous investigations involving the in vitro culture of monocytes
have proven difﬁcult and lead to variable results. Cells under serum-
free conditions are less adherent and differentiate into macrophages
more slowly (Bennett and Breit, 1994), whereas cells incubated with
serum show low survival rates, induced activation, and clumping
(Vincent et al., 1992). In this study, we cultivated primary rat monocytes
under serum-free conditions and compared their survival and cytokine
production in adherent and non-adherent conditions. Preliminary FACS
analysis showed that cells under static conditions express typical surface
markers and are more granular. For further analysis, we evaluated the
inﬂammatory proﬁle of thesemonocytes. These cells secreted high levels
of MCP-1, MIP-2, and TNF-α indicative of cell activation. In support of
these ﬁndings, others have reported that monocytes incubated in
untreated plastic Petri dishes under serum-free conditions secrete high
Fig. 5. Fluorescent microscopy analysis of monocyte interaction with cortical brain slices and rat brain capillary endothelial cells (BCEC). Primary rat monocytes were freshly iso-
lated, labeled with ﬂuorescent dye PKH67 and added to the perfusion system in the presence of cortical organotypic brain slices or BCEC. Cortical brain slices are stained for F-actin
(A) and BCEC are stained for F-actin (E), nuclear DAPI (E, F), and tight junction protein ZO-1 (F) to demonstrate typical structure. Following 24 h incubation, brain slices and
BCEC-monolayers were removed from the glass chamber, washed with PBS, and ﬁxed. Monocyte interaction (i.e. migration and adhesion) was subsequently evaluated using ﬂuo-
rescent microscopy. (B) shows monocytes present in cortical brain slices. (C) displays the round morphology of a migrated monocyte while (D) shows the elongated form of a mi-
grated monocyte. Scale bar in A ~150 μm (A), 50 μm (B), 15 μm (C–F), and 100 μm (G, H).
24 L.A. Hohsﬁeld et al. / Journal of Neuroimmunology 258 (2013) 17–26levels of TNF-α and IL-6 during the ﬁrst week of incubation (Bennett et
al., 1992). Interestingly, we observed that cells treated with LPS show
signiﬁcantly reduced levels of MCP-1 and MIP-2 secretion. IL-1β secre-
tion is slightly, but not signiﬁcantly elevated. This could be due to high
variability between different ELISAs and the relatively low detection
limit of this marker. Previous reports have demonstrated that LPS treat-
ment stimulates cytokine production inmonocytes (Gessani et al., 1993;
Benahmed et al., 1997). It is possible that differences in isolation proce-
dure, incubation period, and/or culture conditions lead to these contra-
dictory results. However, it is also possible that incubating monocytes
in polypropylene tubes leads to an altered response toward LPS.4.3. Monocytes in perfusion
In this study, we were interested in generating a more in vivo-like
culturing method that applies shear stress and simulates constant
blood ﬂow. We demonstrate that perfusion causes cells to undergo a
change in their size and morphology. Cells under constant ﬂow become
signiﬁcantly elongated and larger compared to their freshly isolated
counterparts. In addition, we show that these culturing conditions have
no signiﬁcant impact on cell death. In order to evaluate the function
and inﬂammatory proﬁle of these cells we alsomeasured cytokine levels
present in the circulating medium. We found that under perfusion con-
ditions, monocytes show signiﬁcantly reduced levels of MCP-1, MIP-2,
and TNF-α. These ﬁndings suggest that culturing monocytes under con-
stantﬂow leads to less cell activation compared to those incubated under
static conditions. Furthermore, monocytes demonstrate a slight increase
in cytokine production in response to LPS. This data indicates that the
cells are capable of generating a proper cellular response to LPS and sug-
gests that perfusion is a more physiological culturing method compared
to static conditions. Taken together, these ﬁndings indicate that the in
vitro perfusion system serves as a useful culturing method in studying
the phenotype and function of circulating monocytes.4.4. Monocytes and inﬂammation
Monocytes play an important role during the immune response
(Ziegler-Heitbrock, 2000; Tacke and Randolph, 2006). Upon pathologi-
cal stimulation (including neurodegeneration or inﬂammation in the
brain), monocytes are recruited from the blood ﬂow to adhere to the
BBB (Ley et al., 2007; D'Mello et al., 2009). Following activation from
chemotactic stimuli (e.g. MCP-1 (CCL-2) orMIP-2 (CXCL2)), monocytes
transmigrate across the BBB to the lesion siteswhere they exert their ef-
fector functions (Tanimoto et al., 2007; Khandelwal et al., 2011). They
can produce TNF-α and IL-1β as important immune mediators in re-
sponse to inﬂammatory stimuli (Conroy et al., 2009). In this study, we
show that primary rat monocytes are capable of secreting these inﬂam-
matory cytokines and chemokines and describe a culturing system that
incorporates elements involved in the trafﬁcking of monocytes into the
inﬂamed or diseased brain.
4.5. Monocytes and the blood–brain barrier (BBB)
Previous studies using rat brain endothelial cells under stationary
culture conditions detect basal levels of MCP-1 at 2000–2700 pg/ml
and 5500 pg/ml upon TNF-α stimulation (Harkness et al., 2003). In
our model, using a simple artiﬁcial rat BCEC monolayer incubated
under perfusion conditions, we measured MCP-1 release at approx.
1800 pg/ml. We are the ﬁrst to report constitutive levels of MIP-2 in
rat BCEC. Interestingly, our results indicate that the presence of circu-
lating monocytes has a more signiﬁcant effect on cytokine release
than LPS administration. However, further experiments are needed
in order to understand the mechanisms by which these cells lead to
enhanced cytokine release. It is important to note that our in vitro
BBB does not contain astrocytes. This may explain the limited secre-
tion of the proinﬂammatory cytokines MIP-2, TNF-α, and IL-1β as
well as the absent response from LPS treatment. In previous investi-
gations, we have shown that primary rat monocytes can adhere and
25L.A. Hohsﬁeld et al. / Journal of Neuroimmunology 258 (2013) 17–26transmigrate across this in vitro BBB and subsequently display microglia/
macrophage-like phenotypes (Moser and Humpel, 2007; Böttger et al.,
2010). In the present study we show that monocytes can adhere to an
in vitro BBB when cultured under simulated blood ﬂow. However, this
adhesion is very limited (approximately 11 cells/113 mm2) compared
to the adhesion we have previously observed under static conditions
(1200 cells/113 mm2;Moser andHumpel, 2007). Others have previously
demonstrated that following 6 h incubation 200–300 monocyte-derived
macrophages adhere/migrate through an artiﬁcial BBB (Chung et al.,
2002). These results could differ from our ﬁndings due to differences in
incubation time, the mechanic forces that constant ﬂow puts on cells,
cell type, and/or lack of astrocytes and MCP-1 (as chemotactic stimuli).
In this study we also show that monocytes can interact with
organotypic brain slices (approx. 163 cells/113 mm2). This has also
been conﬁrmed by others that have shown monocyte-derived macro-
phages migrate into hippocampal brain slices to a depth of approxi-
mately 40 μm after 24 h and approximately 80 μm after 72 h (Chung
et al., 2002). Here, we also report changes in cell morphology under
perfusion. Further studies are needed to characterize the differences
between these phenotypes and their meaning on a physiological and
functional level. Future studies involving this model could also evaluate
the differences in monocyte transmigration into diseased vs. non-
diseased brain slices.
4.6. Monocytes and anti-inﬂammatory drugs
We used our in vitro perfusion model in order to screen anti-
inﬂammatory drugs that may counteract the observed elevation in
proinﬂammatory cytokines in organotypic brain slices incubated with
circulating monocytes. Inﬂammation has been implicated in the patho-
genesis of a number of neurodegenerative diseases and epidemiological
studies indicate that the use of non-steroidal anti-inﬂammatory drugs
(NSAID) may decrease their risk (Akiyama et al., 2000; Glass et al.,
2010; Khandelwal et al., 2011). In one study, ibuprofen treatment re-
duced Aβ accumulation, proinﬂammatory cytokine production, andmi-
croglia activation in AD transgenicmice (Wyss-Coray andMucke, 2002).
Minocycline is a broad-spectrum tetracycline antibiotic, but is also
known for its neuroprotective and anti-inﬂammatory properties in neu-
rodegenerative diseases (Blum et al., 2004; Malm et al., 2008; Luzi et al.,
2009). It has been shown to inhibitmacrophage/microglia activation, in-
ﬂammation, and apoptosis by downregulation of pro-inﬂammatory cy-
tokine secretion (Zhang et al., 2009). Our results indicate that these
anti-inﬂammatory drugs alone cannot counteract proinﬂammatory
cytokine production seen in cortical brain slices in the presence of circu-
latingmonocytes. However, it could bepossible that the drug dose, incu-
bation time, or inﬂammatory stimulus (i.e. lack of a diseased brain)were
not optimal for observing an anti-inﬂammatory response. It may also be
possible that amore optimal anti-inﬂammatory therapy requires a com-
bination of drugs rather than a single pharmacological treatment.
4.7. Limitations of this perfusion model
Although this perfusion model allows for the investigation of circu-
lating monocytes, simulating blood ﬂow and shear stress, it also pre-
sents several limitations. First, as with any other plastic culture
system, the monocytes adhere to the plastic and glass components in
our perfusion system. However, it is likely that the adhered monocytes
represent differentiatedmacrophages and that these cells (although ad-
hered) still undergo shear stress and constant ﬂow. We also observed
that the majority of the adhered cells were trypsin insensitive (data
not shown). Unfortunately, these adhered cells cannot be studied in
the system due to the inaccessibility of tubes and glass vessels for im-
munohistochemistry techniques. In addition, we cannot completely ex-
clude thatmediators are sticking to tubes and glass. However, whenwe
evaluated the levels of MCP-1, MIP-2 and TNF-α during perfusion we
only found a very slight decrease in these cytokine levels after 24 h(data not shown). On the other hand, we cannot exclude sticking of
other non-tested mediators, such as LPS. Furthermore, due to the
decreased number of circulating cells following perfusion for 24 h, it is
not possible to perform a detailed cellular analysis (e.g. by FACS,
Western Blot etc.) on these cells. Finally, we cultured monocytes
under serum-free conditions to exclude any exogenous inﬂuences of
serum-derived components. However, in future studies, one may
think of using serumormonocyte-speciﬁc cytokines, to enhance surviv-
al or differentiation. In order to overcome most of these mentioned
problems, it may prove useful to decrease the perfusion time of circulat-
ing monocytes to 1–3 h. In addition, pre-treatment of tubes/glasses
with serum or blocking substrates may also help reduce cell adhesion.
Taken together, this novel perfusion model may allow for the im-
proved study of monocytes under shear stress and simulated blood
ﬂow as well as further exploration of their transmigration and adhe-
sion to an in vitro BBB or organotypic brain slices. Our model also
provides a unique system for screening the use of potential pharma-
ceutical agents on the effects of cell trafﬁcking into the brain. Since
the role of monocytes and monocyte migration in neurological disor-
ders is still controversial, this model could provide answers to this on-
going debate and ultimately help in ﬁnding new ways of interfering
with inﬂammation of diseased brains.
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